Alpha-Fetoprotein (AFP) Tumour Marker Test

The Alpha-Fetoprotein (AFP) tumour Marker Test is a blood test used to measure the levels of alpha-fetoprotein in the blood. Elevated levels of AFP can be associated with certain types of cancers, particularly liver cancer (hepatocellular carcinoma) and germ cell tumours. The AFP Tumour Marker Test is commonly used in the diagnosis, monitoring, and management of these cancers, providing valuable information about the presence and progression of the disease.

Purpose of AFP Tumour Marker Test

The primary purpose of the Alpha-Fetoprotein (AFP) Tumour Marker Test is to aid in the diagnosis and management of certain types of cancer. Specifically, the test is used to:

Detected Liver Cancer

Elevated levels of AFP are often found in people with hepatocellular carcinoma, making this test a valuable tool in the early detection of liver cancer.

Monitor Treatment Effectiveness

For patients undergoing treatment for liver cancer or germ cell tumours, regular AFP tests can help assess how well the treatment is working by tracking changes in AFP levels over time.

Detect Recurrence

Following successful treatment, AFP levels can be monitored to detect any recurrence of cancer at an early stage.

Diagnose Germ Cell tumours

AFP levels can also be elevated in certain types of germ cell tumours, which can occur in the ovaries, testicles, and other areas of the body.

Who Should Consider the AFP Tumour Marker Test?

The AFP Tumour Marker Test may be recommended for people in several different scenarios, including:

  • Patients at Risk for Liver Cancer: People with chronic liver conditions, such as hepatitis B, hepatitis C, or cirrhosis, are at a higher risk of developing hepatocellular carcinoma. Regular AFP testing can aid in early detection.
  • Patients with Suspected Liver Cancer: If a doctor suspects liver cancer based on symptoms or imaging studies, an AFP test can help confirm the diagnosis.
  • People with Germ Cell tumours: Those diagnosed with germ cell tumours, including testicular or ovarian cancer, may undergo AFP testing as part of their diagnostic and monitoring process.
  • Cancer Survivors: Patients who have been treated for liver cancer or germ cell tumours may have regular AFP tests to monitor for recurrence.

Preparation for AFP Tumour Marker Test

Preparation for the AFP Tumour Marker Test is relatively straightforward. Here are the steps and considerations:

No Fasting Required

Unlike some blood tests, there is no need to fast or make dietary changes before an AFP test. Patients can eat and drink as usual.

Medication Review

Patients should inform their healthcare provider about all medications and supplements they are taking, as some substances might affect test results. It is recommended to follow the doctor’s advice on whether to continue or adjust any medications before the test.

Pregnancy Status

Women should inform their doctor if they are pregnant, as AFP levels naturally rise during pregnancy. This information is important for accurate interpretation of the results.

Scheduling the Test

The AFP test is typically scheduled as a routine blood draw at a laboratory or healthcare facility. Patients should confirm the appointment and arrive on time.

Wear Appropriate Clothing

Since the test involves drawing blood from a vein, it is advisable to wear clothing with sleeves that can be easily rolled up.

How is the AFP Tumour Marker Test Conducted?

The AFP Tumour Marker Test is a straightforward procedure performed as a standard blood test. Here is a step-by-step overview of how the test is conducted:

Registration and Consent

Upon arrival, patients will register and may be asked to provide consent for the test.

Sample Collection

A medical specialist will clean the skin on the inside of the elbow or back of the hand with an antiseptic wipe. A tourniquet may be applied to the upper arm to fill the veins with blood, making them more visible.

Blood Draw

The medical specialist inserts a sterile needle into a vein to draw a small amount of blood into a collection tube. Patients may feel a slight prick or pinch during this process.

Post-Collection Care

After the blood is collected, the needle is removed, and pressure is applied to the puncture site to stop any bleeding. A bandage is then placed over the site.

Sample Handling

The collected blood sample is labelled with the patient’s information and sent to a laboratory for analysis. The lab technicians measure the levels of AFP in the blood.

Results

The results are typically available within a few days, depending on the laboratory’s processing time. The doctor will review the results and discuss them with the patient.

Understanding AFP Tumour Marker Test Results

The results of the AFP Tumour Marker Test are typically reported as a numerical value, indicating the level of alpha-fetoprotein (AFP) in the blood. The doctor will consider the results alongside other diagnostic tests and the patient’s overall clinical picture to draw meaningful conclusions. Here is how to understand these results:

  • Normal AFP Levels: For adults, normal AFP levels are generally less than 10 nanograms per millilitre (ng/mL). However, normal ranges can vary slightly depending on the laboratory and the specific methods used.
  • Elevated AFP Levels: Elevated AFP levels can indicate several conditions. In non-pregnant adults, significantly high levels of AFP can be associated with liver cancer (hepatocellular carcinoma), germ cell tumours, and other malignancies. Mildly elevated levels may also be seen in liver diseases such as hepatitis and cirrhosis.
  • Low AFP Levels: Low or undetectable levels of AFP are typically not a cause for concern in non-pregnant adults. In pregnancy, abnormally low AFP levels might warrant further investigation for potential fetal abnormalities.

Interpretation of High AFP Levels

High levels of alpha-fetoprotein (AFP) in the blood can indicate several medical conditions. The interpretation of elevated AFP levels depends on various factors, including the patient’s medical history, clinical symptoms, and other diagnostic tests. Here are some common interpretations of high AFP levels:

One of the most significant causes of elevated AFP levels is hepatocellular carcinoma. High AFP levels can support the diagnosis, especially in individuals with known risk factors such as chronic hepatitis or cirrhosis.

Elevated AFP levels can also indicate the presence of germ cell tumours, such as those originating in the testicles or ovaries. These tumours can produce AFP, making the test useful in their diagnosis and monitoring.

While less common, high AFP levels may be observed in other cancers, including stomach, pancreas, and lung cancers. Elevated AFP in these contexts often suggests a more advanced disease.

Conditions such as chronic hepatitis and cirrhosis can cause moderate increases in AFP levels. These increases are usually not as high as those seen in cancer but can indicate ongoing liver damage or regeneration.

Occasionally, benign conditions such as ataxia-telangiectasia and hereditary tyrosinemia can lead to elevated AFP levels. These instances are rare but should be considered in the differential diagnosis.

Risks and Considerations

The AFP Tumour Marker Test is a simple and generally safe procedure, but it is important to be aware of the potential risks and considerations:

Minimal Physical Risks

The blood draw for the AFP test carries minimal risks, which are common to most blood tests. These can include:

  • Bruising: Some patients may experience minor bruising at the site where the needle was inserted.
  • Discomfort: A slight sting or pinch may be felt when the needle is inserted and removed.
  • Infection: Although rare, there is a small risk of infection at the puncture site.
  • Fainting: A few individuals may feel lightheaded or faint during or after the blood draw.

False Positives

Elevated AFP levels do not always indicate cancer. Non-cancerous liver diseases, such as hepatitis or cirrhosis, can also cause elevated AFP. This can lead to unnecessary anxiety or additional testing.

False Negatives

Normal AFP levels do not entirely rule out the presence of cancer. Some liver cancers or germ cell tumours may not produce significant levels of AFP, especially in the early stages.

Interpretation Challenges

Interpreting AFP levels can be complex and must be done in the context of the patient’s overall health and other diagnostic findings. Misinterpretation can lead to incorrect assumptions about the presence or absence of disease.

Pregnancy Considerations

In pregnant women, AFP levels are naturally higher, and the test is used differently to screen for fetal abnormalities. Abnormal AFP levels in this context require careful interpretation and usually lead to further diagnostic testing.

Our clinics are under the following

insurance panels

For Singaporeans, Singapore Permanent Residents and Foreigners.
Please speak to our friendly clinic staff about using your insurance plans.

Reach Out To Us

We are committed to providing a one-stop experience, where you’ll receive a meticulous consultation and high-quality service in a comfortable environment.

Get Started

Book An Appointment





    image

    • Book An Appointment

    • Media Enquiry

    • Partnership Opportunity



    image

    For faster response, Call Us

    (65) 6733 3383



    Alpha-Fetoprotein (AFP) Tumour Marker Test

    Frequently Asked
    Questions

    How do I prepare for the AFP Tumour Marker Test?

    No special preparation is required for the AFP Tumour Marker Test. Patients should inform their healthcare provider about any medications they are taking and if they are pregnant.

    What do high AFP levels mean?

    High AFP levels can indicate liver cancer, germ cell tumours, or other malignancies. They can also be elevated in non-cancerous liver conditions like hepatitis and cirrhosis.

    Are there any risks associated with the AFP Tumour Marker Test?

    The test is safe with minimal risks, including slight bruising, discomfort at the puncture site, and a rare risk of infection.

    How soon will I get my results?

    Results are typically available within a few days. Your doctor will discuss the results and their implications with you.